CP2 ESTIMATING THE SURVIVAL AND COST IMPACT OF INTRODUCING...

Value in Health 2019 / 05 Vol. 22

CP2 ESTIMATING THE SURVIVAL AND COST IMPACT OF INTRODUCING FIRST-LINE ALECTINIB AND OSIMERTINIB FOR PATIENTS WITH ADVANCED NSCLC: AN ITEN MODEL ASSESSMENT

Moldaver, D., Zhou, A., Grima, D., Hurry, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.025
Date:
May, 2019
File:
PDF, 655 KB
english, 2019
Conversion to is in progress
Conversion to is failed